Polski
PFAS Is Back in the Political Game, While Pharmaceutical Filtration Climbs Higher
This week the filtration industry is buzzing with two very different signals. On one hand, the US is rolling back protections for drinking water against PFAS; on the other, the pharmaceutical filtration market is growing at a pace that's hard to ignore. We take a look at what these developments mean for manufacturers and suppliers of filtration technology.
01 · Water & Regulations
The US Rolls Back Guidance Protecting Drinking Water from PFAS
The US Environmental Protection Agency (EPA) has withdrawn guidance from the Biden administration that encouraged individual states to use their existing authority to limit PFAS — so-called "forever chemicals" — from entering drinking water sources [1]. This is another step in the broader regulatory retreat from this group of compounds, which began back in May 2026 with a proposal to eliminate some of the existing limits [1].
Experts cited by The New Lede, however, urge caution: withdrawing the guidance does not formally change the water quality standards currently in force. The real impact of this decision will likely be seen in practice — in how local authorities issue environmental permits for industry [1]. For companies operating in the water and wastewater treatment space, this means a less clear-cut regulatory signal than just a year ago, but not necessarily a drop in demand for PFAS-removal technologies — where local regulations and public pressure remain strong, demand for effective filtration is unlikely to disappear.
02 · Pharmaceutical Filtration
Pharmaceutical Filtration Market Set to Reach $25.8 Billion by 2032
While US water policy is slowing down, the pharmaceutical filtration segment is speeding up. The latest market report values the global pharmaceutical filtration market at $15.59 billion in 2026, with growth forecast to $25.85 billion by 2032, corresponding to a compound annual growth rate (CAGR) of 8.72% [2].
The scope of this market is broad: it covers filtration used in active pharmaceutical ingredient production, sterile filling, manufacturing of biologics and vaccines, cell and gene therapies, as well as the production of water for injection [2]. Growth is being driven by increasingly stringent regulatory requirements for product purity and the rapid expansion of the biologics sector, which requires far more advanced filtration solutions than traditional pharmaceutical manufacturing.
It's worth juxtaposing these two pieces of news. While regulations around drinking water are loosening in the US, exactly the opposite is happening in pharma — purity requirements are rising, and with them, demand for precise, certified filtration systems. This shows that the industry's future won't move in just one direction: where regulatory pressure eases in one place, quality pressure driven by the development of new therapies grows in another.
Summary
Summary
This week shows just how varied the drivers shaping the filtration market can be — from shifts in US environmental policy to the rapid growth of biologics and gene therapy manufacturing. For manufacturers of filtration technology, this means keeping an eye on both regulations and trends within specific target industries.
We'll be discussing exactly these kinds of changes and their practical implications at the Filtration Technology and Filter Applications Trade Fair – FiltraTEC Expo 2027. Stay tuned for more roundups, and come visit us at the show!
Invitation
From PFAS regulations in drinking water to the rapid growth of filtration for biotech and pharma — these topics show just how wide-ranging the applications of filtration technology are today. Visit FiltraTEC Expo 2027 to discover solutions that address both of these challenges: from water treatment to sterile drug manufacturing. Let's meet at the show and talk about the future of your industry.
FiltraTEC Expo 2027Footnotes
[1] The New Lede — https://www.thenewlede.org/2026/09/epa-withdraws-guidance-preventing-pfas-from-entering-drinking-water/[2] GlobeNewswire — https://www.globenewswire.com/news-release/2026/09/21/3365193/28124/en/the-pharmaceutical-filtration-market-25-8-billion-global-outlook-assessment-2026-2032.html